Etalocib (LY293111) is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5-lipoxygenase. It has antineoplastic activities.
Molekulargewicht:
544.6
Reinheit:
98.92%
CAS Nummer:
[161172-51-6]
Formel:
C33H33FO6
Target-Kategorie:
Apoptosis|||Leukotriene Receptor|||LTR
T22358
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten